Ortho Tri-cyclen Lo
DrugLow dose oral contraceptive
NCT Number: NCT00635570
The ACCEPT study is a Phase IV trial in which women are randomized to either the NuvaRing® vaginal contraceptive ring or a low dose oral contraceptive to assess compliance, side effects, overall acceptability and intent to continue use of the method. The study is focused on the acceptability of the vaginal ring among female undergraduate or graduate students.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Phase 4
University of Chicago, Chicago, Illinois, United States
For many women, college is a time of great change that affects one's social and behavioral practices, including sexual behavior. The first part of the NuvaRing ® Acceptability study is an online survey, developed in conjunction with the University of Illinois's Survey Research Laboratory, which examines women's attitudes and beliefs regarding various methods of birth control. The second part of the study is a comparison trial in which the women are randomized to either the NuvaRing ® vaginal contraceptive ring or a low dose oral contraceptive. The women are followed for three months to assess compliance, side effects, overall acceptability and intent to continue use of the method. Ultimately, we would like college women to be well informed about various methods of contraception available to them and to choose the contraceptive method that best suits their lifestyle.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Low dose oral contraceptive
Contraceptive vaginal ring
Time frame: For the first 3 months
"Perfect use" was defined as reporting never missing a pill or never removing the contraceptive vaginal ring for more than 2 hours during days 1-21 of all three monthly cycles
Time frame: at 3 months
Time frame: at 3 months
Rate of intention to continue the contraceptive method at 3 months
University of Chicago
Other
Acceptability of the NuvaRing Among College and Graduate Students
Acronym: ACCEPT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05556967
Adherence, Patient, Behavior
Jackson, Mississippi, United States
View Trial DetailsNCT07729124
Behavior, Brain Damage, Chronic
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT05832008
Adherence, Patient, Behavior
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT06098690
Adherence, Patient, Behavior
El Paso, Texas, United States
View Trial Details